Your browser doesn't support javascript.
loading
Probiotics in the add-on treatment of otitis media in clinical practice.
Gelardi, M; La Mantia, I; Drago, L; Meroni, G; Aragona, S E; Cupido, G; Vicini, C; Berardi, C; Ciprandi, G.
Afiliação
  • Gelardi M; Department of Otolaryngology, University of Foggia, Foggia, Italy.
  • La Mantia I; Unit of Otolaryngology, Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.
  • Drago L; Microbiology Department, University of Milan, Milan, Italy.
  • Meroni G; Microbiology Department, University of Milan, Milan, Italy.
  • Aragona SE; Center of Regenerative Medicine, Humanitas Mater Domini, Castellanza (VA), Italy.
  • Cupido G; ENT Department, University of Palermo, Palermo, Italy.
  • Vicini C; ENT Department, Forlì-Faenza Hospital, Italy, University of Ferrara e Bologna.
  • Berardi C; ENT Department, Istituto Clinico Città Studi di Milano, Milan, Italy.
  • Ciprandi G; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy.
J Biol Regul Homeost Agents ; 34(6 Suppl. 1): 19-26, 2020.
Article em En | MEDLINE | ID: mdl-33426862
ABSTRACT
Otitis media (OM) affects the middle ear and is typically characterized by earache. OM may be classified as acute (AOM) or chronic (COM), based on symptom duration. OM may be clinically suspected, but the diagnosis is usually confirmed by the otoscopy. Antibiotic therapy is frequently used in clinical practice. However, antibiotics often induce intestinal and respiratory dysbiosis associated with some clinical problems. A one-month course of a probiotic mixture (Abincol® containing Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 million living cells), and Lactobacillus delbrueckii LDD01 (200 million living cells), was prescribed in the Group A, and was compared with no addon treatment, such as the Group B. Patients were evaluated at baseline (T0), at the end of antibiotic treatment (T1), at the end of probiotic course (T2), and at the end of 3-month follow-up (T3).
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: Otite Média / Probióticos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Otite Média / Probióticos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article